Hemophilia A secondary prevention

Hemophilia A Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemophilia A from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemophilia A secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemophilia A secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemophilia A secondary prevention
CDC on Hemophilia A secondary prevention
Hemophilia A secondary prevention in the news
Blogs on Hemophilia A secondary prevention
Directions to Hospitals Treating Hemophilia A
Risk calculators and risk factors for Hemophilia A secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Fahd Yunus, M.D. [2]

Overview

Secondary prevention for hemophilia A is aimed at preventing spontaneous or excessive bleeds in patients who are high risk.

Secondary Prevention

• Patients should be counseled on safe practices and routine accident prevention.
• Patients with moderate-to-severe hemophilia may be managed with prophylactic transfusions of recombinant clotting factor VIII in order to prevent bleeding episodes. The goal of prophylaxis is usually to keep clotting factor levels at 1 percent or greater at all times.
• Routine prophylactic transfusions are not recommended for patients with mild hemophilia.